1 sting criteria and not LS criteria, and 5.
1%
met neither BRCA1/2 nor LS testing criteria.
2 fection events, 1526 met SIRS criteria,
1080 met SOFA criteria, and 378 met qSOFA criteria.
3 search retrieved 1,986 studies, of which
11 met criteria for inclusion (6 RCTs and 5 prospective obs
4 Of 2593 first infection events,
1526 met SIRS criteria, 1080 met SOFA criteria, and 378 met q
5 M performance were predicted by COMT val(
158)
met status.
6 genetic factors (e.g., for WM: COMT val(
158)
met, DAT, BDNF val(66)met).
7 articles identified by literature search,
16 met the eligibility criteria.
8 or pretravel consultation at GTEN sites,
16%
met criteria for MMR vaccination according to the provid
9 INTERPRETATION: RESPONSE-
2 met its primary endpoint.
10 Of the 528 patients, 22.
2%
met BRCA1 and BRCA2 ( BRCA1/2) testing criteria and not
11 th >/=1 occurrence of 692.9, 33.7% and 32.
2%
met the H&R and UKWP criteria.
12 and 174,097 children without) from 1929-
2015 met inclusion criteria.
13 e Hospital between August 2008 and June
2015 met the inclusion criteria and were evaluated in this st
14 -Bev studies published between 2010 and
2016 met the inclusion criteria and were pooled for analysis.
15 Among 405 articles identified,
21 met the initial eligibility criteria and were included i
16 unique articles were identified, of which
23 met inclusion criteria.
17 dialysis at the participating centers;
2300 met our inclusion criteria.
18 Of the 7121 patients in the cohort,
2616 met the primary endpoint (median time to event of 14.5 y
19 1 were selected for full-text review, and
29 met the inclusion criteria, representing 10430 patients
20 iastolic abnormalities, and 7 patients (
29%)
met the definition of diastolic dysfunction.
21 Five hundred sixty-five patients (41.
3%)
met T2D screening criteria, with no difference between c
22 Of 4273 neonates screened, 2022 (47.
3%)
met study criteria.
23 which 208 (6.1%), 274 (8.0%), and 318 (9.
3%)
met the inclusion criteria for analysis of MMR, IG, and
24 ts Among the 29 evaluable patients, only
31%
met Response Evaluation Criteria in Solid Tumors (RECIST
25 SM-IV criteria for bipolar disorder, and
310 met DSM-IV criteria for a manic or hypomanic episode.
26 Of 28 636 articles screened,
3396 met inclusion criteria.
27 mong 374 patients included in the study,
353 met inclusion criteria.
28 itis, 49 met the confirmed definition and
36 met the probable definition.
29 RS criteria, 1080 met SOFA criteria, and
378 met qSOFA criteria.
30 ) met Sepsis-3 criteria, whereas 270 (57.
4%)
met only the old definition.
31 Of 3805 publications retrieved,
42 met inclusion criteria (5 randomized controlled trials a
32 19 patients at 1-week post-treatment and
47%
met criteria for response at 5 weeks.
33 case report forms reporting endocarditis,
49 met the confirmed definition and 36 met the probable def
34 Of the 518 articles found,
49 met the inclusion criteria.
35 Two hundred (42.
5%)
met Sepsis-3 criteria, whereas 270 (57.4%) met only the
36 re taking one, and 19.5% (95% CI, 18.5-20.
5)
met the SPRINT (Systolic Blood Pressure Intervention Tri
37 ecipients, 215 (38%) had UNOS-DGF, 330 (
59%)
met the combined definition, 14 (3%) died, and 23 (4%) h
38 sychosocial and various glycemic measures,
6 met the hierarchical testing criteria of statistical sig
39 For BC, 35.
6%
met one or more select eligibility criteria; of those, 2
40 sis value), 32% had a dFLC <5 mg/dL, and
63%
met criteria for organ R/P.
41 , for WM: COMT val(158)met, DAT, BDNF val(
66)
met).
42 Of 5059 subjects, 592 (11.
7%)
met CVD diagnostic criteria.
43 title/abstract screening, 22 studies (53.
7%)
met the selection criteria.
44 A total 73 of 100 patients (
73%)
met the complete success criteria.
45 tients underwent cataract surgery and 89
731 met inclusion criteria.
46 Forty-one studies (N=30
773)
met inclusion criteria.
47 th >/=1 occurrence of 691.8, 29.9% and 30.
8%
met the H&R and UKWP criteria, respectively.
48 124 (
83%)
met the primary outcome.
49 ches yielded 6959 unique studies, of which
9 met inclusion criteria (comprising 17389 adolescents and
50 n or exclusion using a priori criteria; 3.
9%
met inclusion criteria.
51 Of the 459 people, 18 (3.
9%)
met the criteria for dual-strain infection.
52 Eligible
adults met DSM-IV-R binge-eating disorder criteria and had mode
53 hteen studies (1049 children, 10 057
adults)
met the inclusion criteria.
54 xperts from academia and regulatory
agencies met with chamber operators to list technical, clinical a
55 SCABE criteria were
also met for the major tacrolimus metabolite 13-O-desmethyl t
56 refractory OH VF/VT cardiac arrest who
also met criteria for continuing resuscitation in the CCL.
57 pe, requiring further examination of
altered met abolic pathways and their impact on motor neuron sur
58 terminated when the second interim
analysis met the prespecified futility stopping criteria in the i
59 health analysis and 1138 in the K6
analysis met the DACA eligibility criteria.
60 Results showed that honey samples
analyzed,
met the standard quality criteria set by the EU and were
61 en between Jan 1, 2000, and Jan 9, 2015,
and met the eligibility criteria for inclusion in our study.
62 ents who had been followed up to autopsy
and met inclusion criteria of Lewy body disorder with autops
63 9 subjects followed up, 66 developed CDA
and met criteria for celiac disease and 46 developed only CD
64 how the energetic demands are monitored
and met in response to physiological stimuli remains elusive
65 All the samples presented good quality
and met EU standards for extra-virgin olive oil, but there w
66 he AIM Dysplasia trial, 119 received RFA
and met inclusion criteria.
67 sed noninvasive or invasive ventilation,
and met the American European Consensus Conference definitio
68 A total of 112 submitted
applications met inclusion criteria; of these, 40 (35.7%) were funded
69 these two seemingly conflicting criteria
are met.
70 ycolysis, but strong presynaptic demands
are met preferentially by oxidative phosphorylation, which c
71 ensure that increased thermogenic needs
are met.
72 , the goals of this developmental system
are met by a relatively small group of DNA-binding transcrip
73 tional control demands for switch trials
are met by strengthening task representations in the human b
74 of EMA assays, and 5 of tTG and EMA
assays)
met our inclusion criteria.
75 Review is to summarize criteria that must
be met during design of ligand-targeted drugs (LTDs) to ach
76 s made and remaining challenges that must
be met to ensure a fair and meritocratic approach to resear
77 to define the major challenges that must
be met to make engineered T cells a reliable, safe, and eff
78 f the synthetic organic chemist can often
be met by flow cells operating with recycle of the reactant
79 gies also carries technical challenges to
be met before traditional cell culture and animal testing b
80 shared decision-making preferences would
be met.
81 mposition types termed enterotypes, has
been met with both excitement and controversy.
82 nd performing associations have largely
been met.
83 pecies prior to fundamental tolerances
being met (i.e. the realized niche).
84 ultiple primary MCC were identified; 4
cases met inclusion criteria for next-generation sequencing (N
85 Nine hundred five
cases met the inclusion criteria.
86 Eighty-six
cases met strict inclusion criteria.
87 ldren (28 unilateral and 28 bilateral
cases)
met the study criteria.
88 A total of 1583 (0.02%)
children met the criteria for PH.
89 A total of 1633
children met study criteria.
90 ed in children (aged <18 years), 27
children met the inclusion criteria.
91 dies comprising 1511 patients (all
children)
met eligibility criteria.
92 es (n = 370), 8 in adults and 4 in
children,
met the inclusion criteria.
93 vational studies (217 patients with
cholera)
met the inclusion criteria, with an average two-dose eff
94 Only 37 articles from 373
citations met our inclusion criteria.
95 The PVL Academic Research
Consortium met to review evidence and make recommendations for asse
96 Thirty studies, mainly involving
dentists,
met the inclusion criteria.
97 ETATION: Irinotecan-temozolomide-
dinutuximab met protocol-defined criteria for selection as the combi
98 ion of women who received each elagolix
dose met the clinical response criteria for the two primary e
99 In all, 6303 patients with 8711
encounters met inclusion criteria.
100 A total of 44
eyes met the inclusion criteria.
101 One
family met diagnostic criteria for Lynch syndrome.
102 Total 167 patients (95 males and 72
females)
met the eligibility criteria and were included in the st
103 All admitted patients who
first met the criteria for suspicion of infection in the emerg
104 median of 6 days after T cell therapy;
five met criteria for acute respiratory distress syndrome.
105 urement instruments evaluated, the
following met a priori consensus criteria: EQ-5D and 36-item Short
106 l measures considered for pulmonary
function met consensus criteria for exclusion.
107 LD-tau, 86% of FTLD-TDP, and 88% of FTLD-
FUS met at least 'possible' bvFTD diagnostic criteria at fir
108 m a total of 716 978 administrations of
GBCA met the criteria for inclusion and exclusion.
109 the clinically guided warfarin dosing
group met at least 1 of the end points (absolute difference, 3
110 uided group and 19% in the self-guided
group met the 5% goal.
111 oup, compared with one in the control
group,
met conventional criteria for remission at study end, re
112 ews and 2 evidence-based clinical
guidelines met inclusion criteria.
113 public health, and development of
guidelines met in Potsdam, Germany, to determine the data that shou
114 of physicians and surgeons in the future
has met with varying levels of success.
115 nt of RNA-targeted small molecule probes
has met with limited success.
116 podystrophies with pharmacologic agents
have met with limited success.
117 ecently, emerging molecular diagnostics
have met requirements for speed, low cost, and ease of use fo
118 rward genetic screen identified mutations
in met-1, which encodes an H3K36 methyltransferase, as pote
119 All concussive blast
injuries met the Department of Defense definition of mild, uncomp
120 tients who were assigned to the
intervention met with a PC clinician at least once per month until de
121 -only agriculture produced 23% more food,
it met fewer of the US population's requirements for essent
122 INTERPRETATION: Treatment with
lacosamide met the predefined non-inferiority criteria when compare
123 Our RNA-Seq
libraries met high quality control standards and accurately captur
124 ggestive p < 10-5, and nine independent
loci met this threshold in eight distinct chromosomal regions
125 No
loci met the Bonferroni-adjusted level of statistical signifi
126 rated sound challenge because they no
longer met the inclusion criteria; these participants were excl
127 studies for (18)F-FDG PET-CT and 2 for
LS),
met the inclusion criteria.
128 Three
measures met all 4 criteria; 5, including all 4 claims-based 30-d
129 A subgroup of 493
men met criteria for AAMI based on baseline subjective memor
130 Results Six hundred fifty-three
men met the inclusion criteria.
131 Three tested
metrics met all 4 Prentice criteria for surrogacy for the surrog
132 .3%) received an insertable cardiac
monitor,
met the primary analysis cohort definition, and were obs
133 l annual surface water yields and crop
needs met by surface water allocations from outside the county
134 cts on viremia and clinical response are
not met.
135 er, current complementation systems have
not met the practical requirements as suitable fusion partne
136 of a mate-finding Allee effect, which is
not met by the commonly used minimum mating function.
137 tablished when the success criterion was
not met at 2 consecutive visits at least 3 months after the
138 ce prespecified efficacy thresholds were
not met at the planned interim analysis.
139 usted to the NNPS standards if they were
not met.
140 Overall, 8,112
offspring met the inclusion criteria; 13.6% had a parental hip fra
141 t disease trajectories, physicians are
often met with complex patient histories from which clinical d
142 on of age structure, under assumptions
often met by vertebrate populations, that the stochastic dynam
143 inly two equally-populated fragments is
only met in the highest velocity regime, where the fraction o
144 Sites were notified if a
participant met criteria for an exacerbation and contacted participa
145 All 4,360
participants met DSM-IV criteria for bipolar disorder, and 310 met DS
146 If
participants met prespecified specimen collection criteria, we collec
147 subjects was 40 +/- 9 y; 82% of
participants met the Recommended Daily Allowance (0.8 g .
148 3699 (11%) of these
participants met the COPD criteria and 2903 (78%) were undiagnosed, o
149 studies with a total of 29822
participants)
met the inclusion criteria.
150 78 records (comprising 20,306
participants)
met inclusion criteria and were taken through to data co
151 = 1.79, 95% CI: 1.15, 2.78) versus
partners met online.
152 ipants had higher odds of SDCS with
partners met offline at sex-focused venues (OR = 1.79, 95% CI: 1.
153 Each
patient met with his or her PCP to discuss the report.
154 dies representing a total of 20,048
patients met selection criteria.
155 111 (64.9%) and 106 of 119 (89.1%)
patients met the primary outcome in the early (stage 2 AKI) and d
156 1334
patients met inclusion criteria and were randomly assigned to tre
157 In all, 153
patients met the preliminary diagnostic criteria for PSR: transie
158 At 4.2+/-3 years, 41 (22%)
patients met the composite end point (2.5% deaths and 1% strokes
159 results, 20 unique studies with 224
patients met the inclusion criteria.
160 In all, 2413
patients met the inclusion criteria.
161 , 95% CI 51.3-86.8; p<0.0001) of 28
patients met the criteria for treatment success: 16 (57%) treated
162 A total of 483
patients met the inclusion criteria.
163 Results Overall, 14,554
patients met inclusion criteria (7,906 N0 patients; 6,648 node-po
164 Fifty-five (89%) of the 62
patients met criteria for continuing resuscitation on CCL arrival
165 Thirty-seven (62%)
patients met macular laser criteria at a mean of 19.5 weeks with
166 Overall, 759 (18.7%)
patients met PHQ-9 criteria for depression and 231 (30.4%) were t
167 patients were transferred, only 70
patients met the inclusion criteria during the study period.
168 In all, 59,734
patients met inclusion criteria; 2687 (4.5%) experienced an unpla
169 m August 2010 to December 2016, 793
patients met Z0011 eligibility criteria and had SLN metastases.
170 Fifty-eight adult
patients met the inclusion criteria and participated in the study
171 All
patients met the primary efficacy endpoint: 12 months after gene
172 rty-six thousand nine hundred eight
patients met entry criteria for analysis.
173 Few
patients met American Heart Association criteria for ideal activi
174 Fewer
patients met performance indicators during weekend admission, tim
175 rs; 440 [39%] women), 1074 (94%) of
patients met eligibility criteria.
176 Three-hundred seventeen
patients met inclusion criteria.
177 Ten
patients met selected criteria for analyses of correlations with
178 tion, were measured at the time the
patients met criteria for prolonged mechanical ventilation.
179 Sixty-two (86%) of 72 transported
patients met emergency medical services transport criteria.
180 the study period, of which 32 (27
patients)
met the inclusion criteria.
181 and 57 studies, representing 20892
patients,
met all inclusion criteria.
182 homolog of insulin-degrading enzyme (
PfIDEh)
met our search criteria.
183 Articles that
potentially met inclusion criteria were screened by two investigator
184 omass and overproduce lipids have
previously met with little success.
185 nd morc-1(-) mutants revealed a
progressive,
met-1-dependent enrichment of H3K36me3, suggesting that
186 ealth insurance and 3394 Medicaid
recipients met the study inclusion criteria.
187 Twelve total
references met the inclusion criteria to determine the role of CBCT
188 E10030 (1.5 mg) combination therapy
regimen met the prespecified primary end point of superiority in
189 ing randomisation, both long-acting
regimens met primary criteria for comparability in viral suppress
190 nts, and 173 (57.7%) NYU Langone
respondents met DSM-5 criteria for adult ADHD in the semistructured
191 wed broad inclusion criteria, the novel
RESs met the prespecified criteria for noninferiority compare
192 CI, 1.6,2.6], P value < .0001); both
results met the prespecified success criterion.
193 18 of 1075 articles
reviewed met inclusion criteria, providing data from 67 451 invas
194 (8%) (4 at higher risk and 1 at lower
risk)
met the primary neuroimaging outcome of having T2-weight
195 Forty-four percent of the
sample met criteria for neuropathological diagnosis.
196 6 case-control studies comprising 15
samples met inclusion criteria.
197 No studies for (67)Ga citrate
scintigraphy met the inclusion criteria.
198 232
studies met the inclusion criteria.
199 d from alerts and hand searches; 238
studies met inclusion criteria.
200 After reviewing 4242 records, 75
studies met our inclusion criteria, representing 2 135 314 indiv
201 ull-text review and 97 reports of 81
studies met criteria for inclusion.
202 Eighteen
studies met one randomized controlled trial and 17 observational
203 Twenty-four
studies met the inclusion criteria; 20 studies were included in
204 A total of seven observational
studies met the criteria for inclusion (one for cardiovascular e
205 substitution.Thirteen observational
studies met the eligibility criteria (n < 1700 cases).
206 ontrolled trials and 3 observational
studies met the inclusion criteria.
207 One systematic review and 3 primary
studies met inclusion criteria.
208 Six
studies met the inclusion criteria.
209 Thirteen
studies met the inclusion criteria.
210 Seventy-three
studies met the inclusion criteria for the meta-analysis.
211 Results Thirty-two
studies met inclusion and exclusion criteria, including 3524 ima
212 Although the cohorts from each
study met criteria for switching, they were treated with the i
213 The
study met its main objective, demonstrating a mean best-correc
214 Conclusion The
study met its primary end point; the objective response rate w
215 The
study met PRISMA requirements.
216 INTERPRETATION: The
study met the primary endpoint in all three treatment groups.
217 Conclusion This
study met its primary end points of PFS and TE event rate.
218 Only 8 (2.1%; 95% CI, 0.6%-3.4%)
subjects met the predetermined criteria for an objective and like
219 All
subjects met national IBD surveillance inclusion criteria; 27 wer
220 Four hundred and seventy-eight
subjects met our inclusion criteria.
221 All patients with Schnitzler
syndrome met the Lipsker criteria.
222 studies published between 1980 and 2014
that met our inclusion criteria.
223 We abstracted data from 21 articles
that met inclusion criteria.
224 We identified 235 articles
that met the inclusion criteria, published between 1923 and 2
225 d and EMBASE, we identified 61 articles
that met the inclusion criteria.
226 In total, 49 articles
that met these criteria were identified, which reported 90 co
227 s] and 1697 eyes from healthy controls)
that met published OCT quality control criteria and were suit
228 Of the 5,553,984 patients in the CPRD
that met our inclusion criteria, during the 10-year follow-up
229 y testing for carbapenemase of isolates
that met the CDC CPE surveillance definition.
230 Each time interval of measurement
that met a predetermined criterion was used to generate a val
231 The top 8 outcomes
that met the consensus criteria in round 3 (mean, >/=7.5; med
232 and recorded the number of participants
that met our definition of asthma.
233 We identified 71 publications
that met eligibility criteria.
234 had grade 4 hypoxia related to therapy
that met protocol-defined criteria for unacceptable toxicity.
235 Treatments
that met ESMO benefit thresholds had a lower median increment
236 adings for randomized controlled trials
that met eligibility criteria defined for each question.
237 e eligible for a financial incentive if
they met a 5% cost reduction goal.
238 at were eligible for penalties, in that
they met a volume threshold of 25 admissions over a 3-year pe
239 INTERPRETATION: The
trial met the non-inferiority threshold for the primary endpoi
240 ns were noted with eltrombopag and the
trial met the primary objective of a reduction in CRTEs; eltro
241 stematic reviews and 28 reports of 27
trials met inclusion criteria.
242 41 (38%)
trials met the benefit thresholds in the ESMO framework.
243 Four randomized clinical
trials met the selection criteria and included 1874 unique pati
244 rniture flammability standards are
typically met with chemical flame retardants (FRs).
245 No genetic
variant met the prespecified threshold for statistical significa
246 il a treatment discontinuation criterion
was met.
247 pace where the desired quality criterion
was met.
248 composite criteria for typhoid diagnosis
was met in 24 (77%) of 31 participants in the control group,
249 The primary endpoint
was met in 10% and 60% of placebo- and MABp1-treated patient
250 The primary endpoint
was met in 27 of 30 patients (90%).
251 The primary endpoint
was met only in substudy one (T790M-positive patients).
252 The primary efficacy endpoint
was met with clemastine fumarate treatment, which reduced th
253 the criterion for the primary end point
was met by 2 of 38 patients (5%) who received medical therap
254 The primary efficacy end point
was met by 71.2% versus 69.3%, in the LB and RF groups, resp
255 The primary effectiveness end point
was met, and superiority of DCB over PTA was achieved (83.9%
256 The primary safety end point
was met, and superiority was demonstrated; freedom from a pr
257 dpoint, equivalence of overall response,
was met (271 [87%] of 311 patients with GP2013 and 274 [88%]
258 The prespecified surrogacy threshold
was met, with an R(2)WLS of 0.88 (95% CI, 0.77 to 0.96) and
259 ent with a vaginal ring or IVT over 12
weeks met the primary safety end point.
260 d when prespecified diagnostic criteria
were met (temperature >/=38 degrees C for >/=12 hours and/or
261 The prespecified stopping criteria
were met after the enrollment of 90 of 114 patients.
262 The inclusion criteria
were met by 22 prospective studies exploring various flavonoi
263 ssion or other discontinuation criteria
were met.
264 the 3 months after the switching rules
were met, although all patients continued on their originally
265 6-month visit at which switching rules
were met.
266 and 98% diagnostic accuracy thresholds
were met for FFR-CT values lower than 0.53 or above 0.93 and
267 w model highlights research needs that,
when met, will improve our understanding of carbon cycle dyna
268 a-int = 3.6 x 10(-5) and 6.1 x 10(-5),
which met the multiple-testing corrected threshold of 7.3 x 10
269 g common ground in shared methodology,
which met each discipline's essential evidentiary conditions,
270 We identified 4339 studies, 68 of
which met inclusion criteria, comprising 24 456 adults and 809
271 Men and women (n=150)
who met criteria for DSM-IV alcohol dependence were recruite
272 uary 1, 2012, through December 31, 2013,
who met the inclusion criteria (database cohort).
273 te subfamily A member 4 (ABCA4) gene and
who met the following criteria were enrolled: (1) at least 1
274 2 patients with possible or probable CAA
who met the modified Boston criteria were recruited in a mem
275 Of the 659357 enrollees
who met inclusion criteria (391674 females and 267683 males;
276 undred eighteen patients were identified
who met inclusion criteria.
277 Adult patients were included
who met the QFS criteria according to the Dutch guideline: a
278 ges in health outcomes among individuals
who met key DACA eligibility criteria (based on age at immig
279 e 4934 cases with firearm-related injury
who met the anatomic triage criteria, 884 (17.9%) received i
280 Among the participants
who met the criteria for switching, the CATT participants we
281 Patients
who met at least one response criteria were then randomly as
282 n MLH1 and MSH2 mutations among patients
who met BRCA1/2 testing criteria but did not meet LS testing
283 Among the 86 patients
who met inclusion criteria (49 men [57%]; 37 women [43%]; me
284 Of 4979 patients
who met inclusion criteria, we identified 867 Local patients
285 antly increased screening among patients
who met the American Diabetes Association criteria and adher
286 We analyzed data from 53 patients
who met the criteria for serrated polyposis and 145 patients
287 Of the 6767 patients
who met the inclusion criteria, 2429 were included in the an
288 Among the 12 754 patients
who met the Milan criteria, 2714 were shown to have poor pro
289 ertriaged cases were defined as patients
who met the national anatomic triage criteria for transfer t
290 ure and higher mortality, those patients
who met the old criteria and not Sepsis-3 criteria still dem
291 Patients
who met the primary outcome were more likely to be older, sm
292 and mucosal samples from adult patients
who met the Rome III criteria for IBS at a secondary/tertiar
293 r and proportion of acceptable patients,
who met the CPRD threshold for data quality, in a GP practic
294 ine quarter and 972 in the final quarter
who met inclusion criteria.
295 Eighty treatment-resistant subjects
who met DSM-IV criteria for either major depressive disorder
296 tients required no IAIs, and among those
who met IAI retreatment criteria, a mean of 6.0 IAIs were ad
297 enrolled adolescents (aged 11-18 years)
who met Rome III criteria for abdominal pain-related functio
298 women (mean [SD] age, 40.0 [5.3] years)
who met the inclusion criteria, 5267 (68.5%) had no previous
299 Youths
who met DSM-IV criteria for full or probable diagnoses of se
300 cords were available for 323 women; 54
women met criteria for P-SCAD (4 during pregnancy) and they we